UNIGE document Scientific Article
previous document  unige:8641  next document
add to browser collection

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A

Bi, L.
Lawler, A. M.
High, K. A.
Gearhart, J. D.
Kazazian, H. H.
Published in Nature genetics. 1995, vol. 10, no. 1, p. 119-121
Abstract Haemophilia A is a classic X-linked disease which affects 1 in 5-10,000 males in all populations and is caused by defects in coagulation factor VIII. Roughly 60% of patients have severe disease with factor VIII activity < 1% of normal; they have frequent spontaneous bleeding into joints, soft tissues, muscles and internal organs. These patients usually require regular injections of plasma-derived or recombinant human factor VIII. Because this is expensive and can potentially lead to life-threatening complications, other forms of therapy, including gene therapy, have been proposed. Natural canine models of factor VIII and factor IX deficiency have been available for many years, and gene therapy attempts on these dogs have met with partial success. However, a small animal model of the disease is desirable for studies of factor VIII function and gene therapy. Using gene targeting, we have made a mouse with severe factor VIII deficiency.
Keywords AnimalsBase SequenceBlotting, SouthernCell LineCloning, MolecularDisease Models, AnimalExonsFactor VIII/ geneticsFemaleHemophilia A/ geneticsMaleMiceMice, Inbred C57BLMice, KnockoutMolecular Sequence DataMutagenesis, InsertionalPolymerase Chain Reaction
PMID: 7647782
Full text
(ISO format)
BI, L. et al. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. In: Nature genetics, 1995, vol. 10, n° 1, p. 119-121. doi: 10.1038/ng0595-119 https://archive-ouverte.unige.ch/unige:8641

567 hits

0 download


Deposited on : 2010-07-12

Export document
Format :
Citation style :